Journal article icon

Journal article

All-cause and cause-specific mortality in individuals with COPD in China: a 16-year follow-up cohort study

Abstract:
The prevalence of chronic obstructive pulmonary disease (COPD) is rising in China, yet population-based evidence on COPD-related mortality risk remains limited. This study examined the association between prevalent COPD and all-cause and cause-specific mortality in a large Chinese cohort. 484,301 adults aged 30 to 79 years who received spirometry at the baseline of the China Kadoorie Biobank Study (2004–2008) were included. COPD was defined as FEV1/ FVC < 0.7. Mortality data were tracked via local death registries and national health insurance systems over a median follow-up period of 16.0 years. Cox proportional hazard models and competing risk regression were used to estimate hazard ratios (HRs) and subdistribution HRs (SHRs), respectively. The COPD group had higher all-cause and cause-specific mortality, with adjusted HR (95%CI) for all-cause mortality of 1.44 (1.41–1.47), and adjusted SHR (95%CI) of 1.09 (1.05–1.13), 1.06 (1.01–1.11), 3.30 (3.12–3.49), 1.45 (1.16–1.81), for circulatory disease, neoplasms, respiratory disease, and infectious disease mortality, respectively. Specifically, young COPD (aged < 50 years) showed a stronger mortality association than those aged ≥ 50 years. Moreover, individuals with preserved ratio impaired spirometry (PRISm) had a 1.4-fold higher risk of all-cause mortality compared with non-COPD participants. COPD is associated with a significantly elevated risk of mortality from all causes, circulatory disease, neoplasms, respiratory disease, and infectious disease in the Chinese population. Additionally, young COPD and those with PRISm faced significant mortality burdens.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1007/s10654-025-01252-7

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
ORCID:
0000-0002-9814-0049

Contributors


More from this funder
Funder identifier:
https://ror.org/02wdwnk04
Grant:
CH/1996001/9454
More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MC_UU_00017/1
More from this funder
Funder identifier:
https://ror.org/029chgv08
Grant:
104085/Z/14/Z
088158/Z/09/Z
202922/Z/16/Z
212946/Z/18/Z
More from this funder
Funder identifier:
https://ror.org/054225q67
Grant:
29186
16896
More from this funder
Funder identifier:
https://ror.org/01h0zpd94


Publisher:
Springer Nature
Journal:
European Journal of Epidemiology More from this journal
Volume:
40
Issue:
6
Pages:
681–691
Place of publication:
Netherlands
Publication date:
2025-06-04
Acceptance date:
2025-05-17
DOI:
EISSN:
1573-7284
ISSN:
0393-2990
Pmid:
40465188


Language:
English
Keywords:
Pubs id:
2128128
UUID:
uuid_24593b8c-2f40-4948-bf22-d07097da730a
Local pid:
pubs:2128128
Deposit date:
2025-11-18
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP